CN101732606B - Oral medicinal composition for treating psoriasis - Google Patents
Oral medicinal composition for treating psoriasis Download PDFInfo
- Publication number
- CN101732606B CN101732606B CN201010022946XA CN201010022946A CN101732606B CN 101732606 B CN101732606 B CN 101732606B CN 201010022946X A CN201010022946X A CN 201010022946XA CN 201010022946 A CN201010022946 A CN 201010022946A CN 101732606 B CN101732606 B CN 101732606B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicinal composition
- treatment
- psoriasis
- oral medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an oral medicinal composition for treating psoriasis. The composition comprises the following components in part by weight: 4 to 12 parts of trogopterus dung, 4 to 12 parts of natural indigo, 8 to 24 parts of safflower, 11 to 32 parts of stiff silkworm, 4 to 12 parts of liquoric root, 10 to 30 parts of danshen root, 4 to 12 parts of peach seed, 11 to 34 parts of szechuan lovage rhizome, 4 to 12 parts of buffalo horn, 4 to 12 parts of suberect spatholobus stem, 10 to 30 parts of densefruit pittany root-bark and 9 to 28 parts of lalang grass rhizome. The oral medicinal composition for treating the psoriasis adopts a formula for addressing both symptoms and root causes for detoxicating and cooling blood, clearing heat and moisturizing dryness, and drawing out pus andsterilizing, and can cure intractable psoriasis without relapse.
Description
Technical field
The present invention relates to a kind of herbal composite, particularly, relate to the psoriasic oral medicinal composition of a kind of treatment intractable.
Background technology
The doctor trained in Western medicine theory of psoriasis (also claiming psoriasis) thinks by heredity virus, due to the bacterial infection, direct stimulation, hypoimmunity.Theory of Chinese medical science is thought wind, wet, hot invasion skin histology reduces Abwehrkraft des Koepers, wind syndrome due to blood-deficiency, and noxious dampness is given birth to heat, due to the skin mistake is supported.More accurate fixed theory is still indeterminate so far.Psoriasis is mainly in incidence, extremity, and be symmetrical distribution; Clinical manifestation is for being syringe needle shape or grain of rice shape pimple at first, then increases gradually, and epidermis thickens, and is dry and take off white scales in a large number, and skin lesion place pruritus unbearably.The medical circle common method of treatment is to adopt dexamethasone at present, prednisone, and the treatment of hormonal medicaments such as De Baosong, effect is undesirable, and side effect is big, and drug dependence is strong, easily recurrence.Also having a lot of Chinese herbal and crude drugs preparationses is Main Ingredients and Appearance with Cortex Moutan, Radix Rubiae, Flos Lonicerae, Cortex Dictamni, Spina Gleditsiae, the Fructus Kochiae, Radix Paeoniae Rubra, Poria etc., and pharmacology lacks the effect of hard masses softening and resolving, detoxicating and killing parasites based on detoxifcation, dandruff-removing itching-relieve.In addition, also have some medicine for external use or ointment, external is with playing sterilizing and itch-relieving, lubricated skin, the dry and cracked effect of control, but curative effect does not very significantly reach the purpose of radical cure yet.
Summary of the invention
The objective of the invention is to propose a kind ofly can cure the intractable psoriasis, and cure the Chinese herbal medicine oral medicine that the back is difficult for recurrence, be characterized in instant effect, short treating period, the cure rate height is difficult for recurrence.
For achieving the above object, the invention provides the psoriasic oral medicinal composition of a kind of treatment, said composition comprises following component by weight:
Further, the psoriasic oral medicinal composition of treatment provided by the invention, said composition comprises following component by weight:
Particularly, the component of the optimum formula of the psoriasic oral medicinal composition of treatment provided by the invention is counted by weight:
Particularly, the present invention also provides the preparation method for the treatment of psoriasic oral medicinal composition, comprises following steps: after above each crude drug is pulverized, behind 120 mesh sieves, put into the container mix homogeneously excessively, pour in 270 zero capsules standby.
Oral medicinal composition of the present invention is according to the Chinese medical discrimination theory, owing to human body wind-engaging, cold, wet, heat intrusion skin, causes energy and blood of human body not smooth, qi depression to blood stasis, burning hot turbid damp, failure of skin and muscle to be nourished, intense heat bringing about wind syndrome, wind is contained dryness-transformation, vim and vigour viscous is moved not freely, with the passing of time is empty.Must adopt the detoxifcation removing heat from blood so cure primary disease, clearing heat and moistening dryness, the side of germ-resistant treating both the principal and secondary aspects of a disease that draws out pus by applying a plaster to the affected part just can reach the radical cure effect for the treatment of both the principal and secondary aspects of a disease.Each medicine pharmacology side of this medicine composition separate and monarch as follows:
Monarch drug:
Oletum Trogopterori: removing stasis to stop bleeding, promoting blood circulation and stopping pain;
Indigo Naturalis: heat-clearing and toxic substances removing, removing heat from blood dehumidifying;
Ministerial drug:
Bombyx Batryticatus: relieving spasm by subduing liver-wind, wind-expelling pain-stopping;
Radix Glycyrrhizae: heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription;
Adjuvant drug:
Radix Salviae Miltiorrhizae: blood circulation promoting and blood stasis dispelling, opening becomes silted up leads to;
Flos Carthami: promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing;
Semen Persicae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation;
Messenger drug:
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping;
Cornu Bubali: cold is separated in heat clearing away, the detoxifcation speckle removing;
Caulis Spatholobi: blood circulation promoting and enriching, relaxing muscles and tendons to promote blood circulation;
Cortex Dictamni: heat clearing and damp drying, detoxifcation is dispeled the wind;
Rhizoma Imperatae: cooling blood for hemostasis, clearing away heat and promoting diuresis.
Treatment psoriasis oral medicinal composition of the present invention adopts the detoxifcation removing heat from blood, clearing heat and moistening dryness according to the differential diagnosis in tcm theory, the side of germ-resistant treating both the principal and secondary aspects of a disease that draws out pus by applying a plaster to the affected part, in 3 years, the inventor uses the treatment of this medicine to 210 routine psoriatics and observes in the past, after the medication, 182 examples are cured.Cure rate reaches 87%.Effective 208 examples of medication, effective percentage is 99%.
The specific embodiment
Below in conjunction with embodiment technical scheme of the present invention is further described:
Embodiment 1
Raw material with following parts by weight:
Pulverize with pulverizer, behind 120 mesh sieves, put into the container mix homogeneously excessively, pour in 270 (consumption of the moon or a course of treatment) zero capsules standby.
Embodiment 2
Raw material with following parts by weight:
Pulverize with pulverizer, behind 120 mesh sieves, put into the container mix homogeneously excessively, pour in 270 (consumption of the moon or a course of treatment) zero capsules standby.
Embodiment 3
Raw material with following parts by weight:
Pulverize with pulverizer, behind 120 mesh sieves, put into the container mix homogeneously excessively, pour in 270 (consumption of the moon or a course of treatment) zero capsules standby.
Embodiment 4
Raw material with following parts by weight:
Pulverize with pulverizer, behind 120 mesh sieves, put into the container mix homogeneously excessively, pour in 270 (consumption of the moon or a course of treatment) zero capsules standby.
Embodiment 5
Raw material with following parts by weight:
Pulverize with pulverizer, behind 120 mesh sieves, put into the container mix homogeneously excessively, pour in 270 (consumption of the moon or a course of treatment) zero capsules standby.
Using method: drink yellow wine half two before sleeping every day earlier, take 9 of this medicines; Serveing on 30 days is a course of treatment.Visible scurf reduced the instant effect person at 10 days, and the erythema color is thin out; Take medicine after about 1 to 3 course of treatment, the skin lesion at dermatosis place begins to disappear, and begins the skin that makes new advances of growing.Use the basic recovery process of each stage disease of this medicine:
1. take second week of this medicine back:
The thick bits attenuation of whole body psoriasis pathological changes place's epidermis, scurf slightly reduces, and surface sclerosis skin limbers up slightly, and skin pruritus obviously reduces.
2. take back around this medicine the:
Surface skin lesion thickened section position scaling of skin layer attenuation, the red inflammatory erythra of substrate color dodge, after surperficial squama was scraped, desquamation reduced, and the thin film phenomenon is not obvious, and petechial hemorrhage is few, and skin lesion place skin is obviously soft.
3. take the 6th week of this medicine back:
Former skin lesion peony erythra becomes pale red, and the little skin lesion of drop shape obviously reduces, and map shape erythra edge is gradually flat, surperficial chipless, and the skin gradual change of former desquamation place is smooth, and scratchiness disappears substantially.
4. take eight week of this medicine back:
The skin lesion place becomes pale pink, the basic chipless in surface, and nothing is itched, and does not have newborn erythra.
5. take the 12 week of this medicine back:
Epidermis reverts to light pink color substantially, and the calm speckle of a small amount of protochrome is arranged, chipless, and smooth, nothing is itched, and does not have newborn erythra.
The psoriasic oral medicinal composition of treatment provided by the invention is used for clinical embodiment:
Embodiment 6
Patient's name: old XX, woman, 30 years old, people from Shanghai City, company manager.Suffered from psoriasis 15 years.Before 15 years because of heavy cold, after the hyperpyrexia, general psoriasis of whole body, from scalp, face, trunk and extremity whole body are covered with psoriasis.Almost there is not normal skin.The multiple thick crust in surface is scratched the back and is formed white squama, and a large amount of white decortications were gone to many China famous hospitals in 15 years, used up Chinese medicine, and Western medicine and hormone are all invalid.After autumn in 2008, the court used the psoriasic oral medicinal composition of treatment of the present invention to treat a course of treatment, beginning effectively; Four recoveries from illness course of treatment; Follow up a case by regular visits to so far and do not recur.
Embodiment 7
Patient's name: Cao XX, man, 35 years old, people from Shanghai City, manager.Suffered from psoriasis 10 years.Before 10 years, happen suddenly in Tou Mian Bu Red mottle rash, violent pruritus is accompanied in a large amount of decortications.Be diagnosed as psoriasis in specialist hospital, use up various Western medicine, Chinese medicine, hormone, and after the elapid Drug therapy, the state of an illness does not have improvement, and spreads to whole body, is in a bad way.The extremity skin ulceration is to such an extent as to can't wear short sweater and pants summer.Have a strong impact on work and life.After coming the court to use the psoriasic oral medicinal composition treatment of treatment of the present invention, take effect a course of treatment, three recoveries from illness course of treatment; So far do not recur.
Embodiment 8
Patient's name: Jiang XX, woman, 24 years old, Shanghai people, restaurant manager.Suffered from psoriasis 2 years.Before 2 years, because of flu head and facial Tu Red mottle rash, the multiple thick crust in surface is scratched the back and is formed white squama, a large amount of white decortications.Many tame hospital diagnosis are psoriasis.The patient adopts western medicines in treatment always, and all invalid, the state of an illness is more and more heavier,, is in a bad way to facial from the crown, almost disfeatures.Patient's emotion is extremely low, loses treatment confidence, can't operate as normal.Also bring immense pressure economically.After coming the court to use the psoriasic oral medicinal composition treatment of treatment of the present invention, take a turn for the better a course of treatment, three recoveries from illness course of treatment; Follow up a case by regular visits to so far and do not recur.
The present invention is according to the Chinese medical discrimination theory, adopt the detoxifcation removing heat from blood, clearing heat and moistening dryness, the side of germ-resistant treating both the principal and secondary aspects of a disease that draws out pus by applying a plaster to the affected part is a monarch drug with Oletum Trogopterori, Indigo Naturalis, and Bombyx Batryticatus, Radix Glycyrrhizae are ministerial drug, Radix Salviae Miltiorrhizae, Flos Carthami, Semen Persicae are adjuvant drug, Rhizoma Chuanxiong, Cornu Bubali, Caulis Spatholobi, Cortex Dictamni, Rhizoma Imperatae are the pharmaceutical composition of messenger drug, and this pharmaceutical composition can be cured the intractable psoriasis, and cure the difficult recurrence in back.
Although content of the present invention has been done detailed introduction by above preferred embodiment, will be appreciated that above-mentioned description should not be considered to limitation of the present invention.After those skilled in the art have read foregoing, for multiple modification of the present invention with to substitute all will be conspicuous.Therefore, protection scope of the present invention should be limited to the appended claims.
Claims (4)
4. as any psoriasic oral medicinal composition of described treatment in the claim 1~3, it is characterized in that, described compositions be adopt described ratio component after crushed uniform mixing form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010022946XA CN101732606B (en) | 2010-01-19 | 2010-01-19 | Oral medicinal composition for treating psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010022946XA CN101732606B (en) | 2010-01-19 | 2010-01-19 | Oral medicinal composition for treating psoriasis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101732606A CN101732606A (en) | 2010-06-16 |
CN101732606B true CN101732606B (en) | 2011-08-10 |
Family
ID=42456974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010022946XA Expired - Fee Related CN101732606B (en) | 2010-01-19 | 2010-01-19 | Oral medicinal composition for treating psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101732606B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105168798A (en) * | 2015-08-14 | 2015-12-23 | 殷永洲 | Hundred-flower syrup for treatment of psoriasis and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174737A (en) * | 1997-07-12 | 1998-03-04 | 迟经惠 | Pill for type of tubercular disease found in women, usu. characterized by menoustasis recurent low fever and general degility. |
CN101066334A (en) * | 2007-06-08 | 2007-11-07 | 焦彬 | Chinese medicine composition for eliminating oral bad smell and its prepn |
-
2010
- 2010-01-19 CN CN201010022946XA patent/CN101732606B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174737A (en) * | 1997-07-12 | 1998-03-04 | 迟经惠 | Pill for type of tubercular disease found in women, usu. characterized by menoustasis recurent low fever and general degility. |
CN101066334A (en) * | 2007-06-08 | 2007-11-07 | 焦彬 | Chinese medicine composition for eliminating oral bad smell and its prepn |
Also Published As
Publication number | Publication date |
---|---|
CN101732606A (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1302805C (en) | Ready prepared Chinese medicine for preventing and treating brain apoplexia | |
CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
CN102178800A (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN102836177A (en) | Traditional Chinese medicine preparation for treating osteopathia | |
CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN103432551B (en) | Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia | |
CN102293853A (en) | Chinese medicinal pills for treating Bi syndrome | |
CN101732606B (en) | Oral medicinal composition for treating psoriasis | |
CN102357215B (en) | Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis | |
CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
CN102657761A (en) | Patch for treating rheumatoid arthritis and preparation method for patch | |
CN103223078A (en) | Traditional Chinese medicine used for treating knee osteoarthritis through iontophoresis | |
CN101732425B (en) | Externally-applied medicine composite for psoriasis | |
CN106267098A (en) | A kind of can effective Chinese medicine composition treating gout and preparation method thereof | |
CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
CN103961490A (en) | Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof | |
CN103585483A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
CN103110722B (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
CN106074694A (en) | A kind of Spica Prunellae eczema lotion | |
CN104338086A (en) | Chinese medicinal enema for treating chronic endometritis and preparation method thereof | |
CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale | |
CN104623050B (en) | A kind of medicament for the treatment of corticosteroid femur head necrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20170119 |
|
CF01 | Termination of patent right due to non-payment of annual fee |